{"entity":{"type":"insider","cik":"0001640033","url":"/insider/0001640033","json_url":"/insider/0001640033.json","name":"NEA 15 GP, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":44,"n_filings":28,"first":"2016-01-14","last":"2025-10-06","span_basis":"filed_date"},"name_variants":[{"name":"NEA 15 GP, LLC","source":"filing","n_filings":28,"first_seen":"2016-01-14","last_seen":"2025-10-06"}],"transactions":[{"id":4906020,"accession":"0001193125-25-232129","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001193125-25-232129","line_url":"/filing/0001193125-25-232129#line-5","is_derivative":false,"issuer_cik":"0001640033","issuer_name":"NeueHealth, Inc.","issuer_ticker":"NEUE","issuer_name_source":null,"issuer_url":"/issuer/0001640033","owner_cik":"0001640033","owner_name":"NEA 15 GP, LLC","owner_display_name":"NEA 15 GP, LLC","owner_url":"/insider/0001640033","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":280.0,"shares_display":"280","price_per_share":6.75,"price_display":"6.75","price_state":"stated","total_value":1890.0,"total_display":"1,890.00","total_whole":"1,890","shares_owned_after":1526937.0,"shares_owned_after_display":"1,526,937","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-10-02","filed_date":"2025-10-06","scope":"insider"},{"id":6852647,"accession":"0001209191-22-038994","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-038994","line_url":"/filing/0001209191-22-038994#line-1","is_derivative":false,"issuer_cik":"0001237289","issuer_name":"Arcellx, Inc.","issuer_ticker":"ACLX","issuer_name_source":null,"issuer_url":"/issuer/0001237289","owner_cik":null,"owner_name":"Florence Anthony A. Jr.; Sonsini Peter W.; SANDELL SCOTT D; New Enterprise Associates 15, L.P.; NEA Partners 15, L.P.; Makhzoumi Mohamad; NEA 15 GP, LLC; BASKETT FOREST","owner_display_name":"Florence Anthony A. Jr.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":312500.0,"shares_display":"312,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","total_whole":"5,000,000","shares_owned_after":6745262.0,"shares_owned_after_display":"6,745,262","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-21","filed_date":"2022-06-23","scope":"insider"},{"id":6373300,"accession":"0001209191-22-032835","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-032835","line_url":"/filing/0001209191-22-032835#line-3","is_derivative":false,"issuer_cik":"0001237289","issuer_name":"IonQ, Inc.","issuer_ticker":"IONQ","issuer_name_source":null,"issuer_url":"/issuer/0001237289","owner_cik":null,"owner_name":"Makhzoumi Mohamad; Florence Anthony A. Jr.; New Enterprise Associates 15, L.P.; NEA 15 GP, LLC; Sonsini Peter W.; SANDELL SCOTT D; BASKETT FOREST; NEA Partners 15, L.P.","owner_display_name":"Makhzoumi Mohamad","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":498614.0,"shares_display":"498,614","price_per_share":5.6464,"price_display":"5.65","price_state":"stated","total_value":2815374.0896,"total_display":"2,815,374.09","total_whole":"2,815,374","shares_owned_after":26306693.0,"shares_owned_after_display":"26,306,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-31","filed_date":"2022-05-31","scope":"insider"},{"id":6373297,"accession":"0001209191-22-032835","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-032835","line_url":"/filing/0001209191-22-032835#line-2","is_derivative":false,"issuer_cik":"0001237289","issuer_name":"IonQ, Inc.","issuer_ticker":"IONQ","issuer_name_source":null,"issuer_url":"/issuer/0001237289","owner_cik":null,"owner_name":"Makhzoumi Mohamad; Florence Anthony A. Jr.; New Enterprise Associates 15, L.P.; NEA 15 GP, LLC; Sonsini Peter W.; SANDELL SCOTT D; BASKETT FOREST; NEA Partners 15, L.P.","owner_display_name":"Makhzoumi Mohamad","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1497733.0,"shares_display":"1,497,733","price_per_share":5.9292,"price_display":"5.93","price_state":"stated","total_value":8880358.5036,"total_display":"8,880,358.50","total_whole":"8,880,359","shares_owned_after":26805307.0,"shares_owned_after_display":"26,805,307","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-27","filed_date":"2022-05-31","scope":"insider"},{"id":6373294,"accession":"0001209191-22-032835","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-032835","line_url":"/filing/0001209191-22-032835#line-1","is_derivative":false,"issuer_cik":"0001237289","issuer_name":"IonQ, Inc.","issuer_ticker":"IONQ","issuer_name_source":null,"issuer_url":"/issuer/0001237289","owner_cik":null,"owner_name":"Makhzoumi Mohamad; Florence Anthony A. Jr.; New Enterprise Associates 15, L.P.; NEA 15 GP, LLC; Sonsini Peter W.; SANDELL SCOTT D; BASKETT FOREST; NEA Partners 15, L.P.","owner_display_name":"Makhzoumi Mohamad","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":926619.0,"shares_display":"926,619","price_per_share":5.8036,"price_display":"5.80","price_state":"stated","total_value":5377726.0284,"total_display":"5,377,726.03","total_whole":"5,377,726","shares_owned_after":28303040.0,"shares_owned_after_display":"28,303,040","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-26","filed_date":"2022-05-31","scope":"insider"},{"id":6344789,"accession":"0001209191-22-008192","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-008192","line_url":"/filing/0001209191-22-008192#line-2","is_derivative":false,"issuer_cik":"0001237289","issuer_name":"Arcellx, Inc.","issuer_ticker":"ACLX","issuer_name_source":null,"issuer_url":"/issuer/0001237289","owner_cik":null,"owner_name":"Florence Anthony A. Jr.; BASKETT FOREST; NEA 15 GP, LLC; Makhzoumi Mohamad; SANDELL SCOTT D; Sonsini Peter W.; NEA Partners 15, L.P.; New Enterprise Associates 15, L.P.","owner_display_name":"Florence Anthony A. Jr.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":8,"other_reporting_owners":7,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1583333.0,"shares_display":"1,583,333","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":23749995.0,"total_display":"23,749,995.00","total_whole":"23,749,995","shares_owned_after":6432762.0,"shares_owned_after_display":"6,432,762","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-08","filed_date":"2022-02-09","scope":"insider"},{"id":5397832,"accession":"0001209191-21-026862","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-026862","line_url":"/filing/0001209191-21-026862#line-3","is_derivative":false,"issuer_cik":"0001235952","issuer_name":"Reneo Pharmaceuticals, Inc.","issuer_ticker":"RPHM","issuer_name_source":null,"issuer_url":"/issuer/0001235952","owner_cik":null,"owner_name":"Sonsini Peter W.; NEA 15 GP, LLC; New Enterprise Associates 15, L.P.; SANDELL SCOTT D; NEA Partners 15, L.P.; BASKETT FOREST; Makhzoumi Mohamad; MAKOWER JOSHUA; Florence Anthony A. Jr.","owner_display_name":"Sonsini Peter W.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":9,"other_reporting_owners":8,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":666666.0,"shares_display":"666,666","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":9999990.0,"total_display":"9,999,990.00","total_whole":"9,999,990","shares_owned_after":4785494.0,"shares_owned_after_display":"4,785,494","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-13","filed_date":"2021-04-15","scope":"insider"},{"id":2658626,"accession":"0001209191-20-055616","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-20-055616","line_url":"/filing/0001209191-20-055616#line-6","is_derivative":false,"issuer_cik":"0001629794","issuer_name":"Eargo, Inc.","issuer_ticker":"EAR","issuer_name_source":null,"issuer_url":"/issuer/0001629794","owner_cik":null,"owner_name":"New Enterprise Associates 15, L.P.; NEA 15 GP, LLC; NEA Partners 15, L.P.","owner_display_name":"New Enterprise Associates 15, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":311111.0,"shares_display":"311,111","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":5599998.0,"total_display":"5,599,998.00","total_whole":"5,599,998","shares_owned_after":6520017.0,"shares_owned_after_display":"6,520,017","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-20","filed_date":"2020-10-22","scope":"insider"},{"id":3011054,"accession":"0001209191-20-043880","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-043880","line_url":"/filing/0001209191-20-043880#line-3","is_derivative":false,"issuer_cik":"0001629794","issuer_name":"Inozyme Pharma, Inc.","issuer_ticker":"INZY","issuer_name_source":null,"issuer_url":"/issuer/0001629794","owner_cik":null,"owner_name":"New Enterprise Associates 15, L.P.; NEA Partners 15, L.P.; NEA 15 GP, LLC","owner_display_name":"New Enterprise Associates 15, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":4000000.0,"total_display":"4,000,000.00","total_whole":"4,000,000","shares_owned_after":2437689.0,"shares_owned_after_display":"2,437,689","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-28","filed_date":"2020-07-28","scope":"insider"},{"id":2220017,"accession":"0001209191-20-042657","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-042657","line_url":"/filing/0001209191-20-042657#line-3","is_derivative":false,"issuer_cik":"0001629794","issuer_name":"Nkarta, Inc.","issuer_ticker":"NKTK","issuer_name_source":null,"issuer_url":"/issuer/0001629794","owner_cik":null,"owner_name":"New Enterprise Associates 15, L.P.; NEA 15 GP, LLC; NEA Partners 15, L.P.","owner_display_name":"New Enterprise Associates 15, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":666666.0,"shares_display":"666,666","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":11999988.0,"total_display":"11,999,988.00","total_whole":"11,999,988","shares_owned_after":2902115.0,"shares_owned_after_display":"2,902,115","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-14","filed_date":"2020-07-16","scope":"insider"},{"id":2287259,"accession":"0001209191-20-038234","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-038234","line_url":"/filing/0001209191-20-038234#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS, INC.","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":null,"owner_name":"New Enterprise Associates 15, L.P.; Growth Equity Opportunities Fund IV, LLC; NEA 15 GP, LLC; NEA Partners 15, L.P.","owner_display_name":"New Enterprise Associates 15, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1428571.0,"shares_display":"1,428,571","price_per_share":5.25,"price_display":"5.25","price_state":"stated","total_value":7499997.75,"total_display":"7,499,997.75","total_whole":"7,499,998","shares_owned_after":3952958.0,"shares_owned_after_display":"3,952,958","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-19","filed_date":"2020-06-22","scope":"insider"},{"id":8558065,"accession":"0001209191-19-023995","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-023995","line_url":"/filing/0001209191-19-023995#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":null,"owner_name":"NEA 15 GP, LLC; NEA Partners 15, L.P.; Growth Equity Opportunities Fund IV, LLC; New Enterprise Associates 15, L.P.","owner_display_name":"NEA 15 GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4347827.0,"shares_display":"4,347,827","price_per_share":1.14,"price_display":"1.14","price_state":"stated","total_value":4956522.78,"total_display":"4,956,522.78","total_whole":"4,956,523","shares_owned_after":25243865.0,"shares_owned_after_display":"25,243,865","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-04-08","filed_date":"2019-04-08","scope":"insider"},{"id":6609840,"accession":"0001209191-18-064024","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-064024","line_url":"/filing/0001209191-18-064024#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":null,"owner_name":"NEA Partners 15, L.P.; Growth Equity Opportunities IV, LLC; NEA 15 GP, LLC; New Enterprise Associates 15, L.P.","owner_display_name":"NEA Partners 15, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300000.0,"shares_display":"300,000","price_per_share":1.4946,"price_display":"1.49","price_state":"stated","total_value":448380.0,"total_display":"448,380.00","total_whole":"448,380","shares_owned_after":20896038.0,"shares_owned_after_display":"20,896,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-21","filed_date":"2018-12-21","scope":"insider"},{"id":6609836,"accession":"0001209191-18-064024","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-064024","line_url":"/filing/0001209191-18-064024#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":null,"owner_name":"NEA Partners 15, L.P.; Growth Equity Opportunities IV, LLC; NEA 15 GP, LLC; New Enterprise Associates 15, L.P.","owner_display_name":"NEA Partners 15, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":1.6303,"price_display":"1.63","price_state":"stated","total_value":326060.0,"total_display":"326,060.00","total_whole":"326,060","shares_owned_after":20596038.0,"shares_owned_after_display":"20,596,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-20","filed_date":"2018-12-21","scope":"insider"},{"id":6157106,"accession":"0001209191-18-062247","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-062247","line_url":"/filing/0001209191-18-062247#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":null,"owner_name":"NEA Partners 15, L.P.; Growth Equity Opportunities IV, LLC; NEA 15 GP, LLC; New Enterprise Associates 15, L.P.","owner_display_name":"NEA Partners 15, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":61200.0,"shares_display":"61,200","price_per_share":1.9785,"price_display":"1.98","price_state":"stated","total_value":121084.2,"total_display":"121,084.20","total_whole":"121,084","shares_owned_after":20396038.0,"shares_owned_after_display":"20,396,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-11","filed_date":"2018-12-12","scope":"insider"},{"id":6080396,"accession":"0001209191-18-061832","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-061832","line_url":"/filing/0001209191-18-061832#line-3","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":null,"owner_name":"New Enterprise Associates 15, L.P.; NEA 15 GP, LLC; NEA Partners 15, L.P.; Growth Equity Opportunities IV, LLC","owner_display_name":"New Enterprise Associates 15, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26000.0,"shares_display":"26,000","price_per_share":1.9837,"price_display":"1.98","price_state":"stated","total_value":51576.2,"total_display":"51,576.20","total_whole":"51,576","shares_owned_after":20334838.0,"shares_owned_after_display":"20,334,838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-10","filed_date":"2018-12-10","scope":"insider"},{"id":6080394,"accession":"0001209191-18-061832","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-061832","line_url":"/filing/0001209191-18-061832#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":null,"owner_name":"New Enterprise Associates 15, L.P.; NEA 15 GP, LLC; NEA Partners 15, L.P.; Growth Equity Opportunities IV, LLC","owner_display_name":"New Enterprise Associates 15, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":117100.0,"shares_display":"117,100","price_per_share":1.9843,"price_display":"1.98","price_state":"stated","total_value":232361.53,"total_display":"232,361.53","total_whole":"232,362","shares_owned_after":20308838.0,"shares_owned_after_display":"20,308,838","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-07","filed_date":"2018-12-10","scope":"insider"},{"id":6080390,"accession":"0001209191-18-061832","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-061832","line_url":"/filing/0001209191-18-061832#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":null,"owner_name":"New Enterprise Associates 15, L.P.; NEA 15 GP, LLC; NEA Partners 15, L.P.; Growth Equity Opportunities IV, LLC","owner_display_name":"New Enterprise Associates 15, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":27300.0,"shares_display":"27,300","price_per_share":1.9932,"price_display":"1.99","price_state":"stated","total_value":54414.36,"total_display":"54,414.36","total_whole":"54,414","shares_owned_after":20191738.0,"shares_owned_after_display":"20,191,738","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-06","filed_date":"2018-12-10","scope":"insider"},{"id":6397775,"accession":"0001209191-18-060414","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-060414","line_url":"/filing/0001209191-18-060414#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":null,"owner_name":"Growth Equity Opportunities IV, LLC; NEA Partners 15, L.P.; New Enterprise Associates 15, L.P.; NEA 15 GP, LLC","owner_display_name":"Growth Equity Opportunities IV, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":71900.0,"shares_display":"71,900","price_per_share":1.9759,"price_display":"1.98","price_state":"stated","total_value":142067.21,"total_display":"142,067.21","total_whole":"142,067","shares_owned_after":20164438.0,"shares_owned_after_display":"20,164,438","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-30","filed_date":"2018-11-30","scope":"insider"},{"id":6397772,"accession":"0001209191-18-060414","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-060414","line_url":"/filing/0001209191-18-060414#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":null,"owner_name":"Growth Equity Opportunities IV, LLC; NEA Partners 15, L.P.; New Enterprise Associates 15, L.P.; NEA 15 GP, LLC","owner_display_name":"Growth Equity Opportunities IV, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":24500.0,"shares_display":"24,500","price_per_share":1.9928,"price_display":"1.99","price_state":"stated","total_value":48823.6,"total_display":"48,823.60","total_whole":"48,824","shares_owned_after":20092538.0,"shares_owned_after_display":"20,092,538","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-28","filed_date":"2018-11-30","scope":"insider"},{"id":6588853,"accession":"0001209191-18-059729","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-059729","line_url":"/filing/0001209191-18-059729#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":null,"owner_name":"Growth Equity Opportunities IV, LLC; NEA Partners 15, L.P.; NEA 15 GP, LLC; New Enterprise Associates 15, L.P.","owner_display_name":"Growth Equity Opportunities IV, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":170000.0,"shares_display":"170,000","price_per_share":1.9771,"price_display":"1.98","price_state":"stated","total_value":336107.0,"total_display":"336,107.00","total_whole":"336,107","shares_owned_after":20068038.0,"shares_owned_after_display":"20,068,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-20","filed_date":"2018-11-21","scope":"insider"},{"id":6427049,"accession":"0001209191-18-059344","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-059344","line_url":"/filing/0001209191-18-059344#line-3","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":null,"owner_name":"NEA 15 GP, LLC; Growth Equity Opportunities IV, LLC; New Enterprise Associates 15, L.P.; NEA Partners 15, L.P.","owner_display_name":"NEA 15 GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":510000.0,"shares_display":"510,000","price_per_share":1.8758,"price_display":"1.88","price_state":"stated","total_value":956658.0,"total_display":"956,658.00","total_whole":"956,658","shares_owned_after":19898038.0,"shares_owned_after_display":"19,898,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-19","filed_date":"2018-11-19","scope":"insider"},{"id":6427046,"accession":"0001209191-18-059344","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-059344","line_url":"/filing/0001209191-18-059344#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":null,"owner_name":"NEA 15 GP, LLC; Growth Equity Opportunities IV, LLC; New Enterprise Associates 15, L.P.; NEA Partners 15, L.P.","owner_display_name":"NEA 15 GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":350000.0,"shares_display":"350,000","price_per_share":1.8553,"price_display":"1.86","price_state":"stated","total_value":649355.0,"total_display":"649,355.00","total_whole":"649,355","shares_owned_after":19388038.0,"shares_owned_after_display":"19,388,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-16","filed_date":"2018-11-19","scope":"insider"},{"id":6427044,"accession":"0001209191-18-059344","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-059344","line_url":"/filing/0001209191-18-059344#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":null,"owner_name":"NEA 15 GP, LLC; Growth Equity Opportunities IV, LLC; New Enterprise Associates 15, L.P.; NEA Partners 15, L.P.","owner_display_name":"NEA 15 GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":340000.0,"shares_display":"340,000","price_per_share":1.8587,"price_display":"1.86","price_state":"stated","total_value":631958.0,"total_display":"631,958.00","total_whole":"631,958","shares_owned_after":19038038.0,"shares_owned_after_display":"19,038,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-15","filed_date":"2018-11-19","scope":"insider"},{"id":6707414,"accession":"0001209191-18-047958","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-047958","line_url":"/filing/0001209191-18-047958#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":null,"owner_name":"New Enterprise Associates 15, L.P.; Growth Equity Opportunities IV, LLC; NEA Partners 15, L.P.; NEA 15 GP, LLC","owner_display_name":"New Enterprise Associates 15, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":663716.0,"shares_display":"663,716","price_per_share":2.26,"price_display":"2.26","price_state":"stated","total_value":1499998.16,"total_display":"1,499,998.16","total_whole":"1,499,998","shares_owned_after":18698038.0,"shares_owned_after_display":"18,698,038","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-21","filed_date":"2018-08-22","scope":"insider"},{"id":6726443,"accession":"0001209191-18-043476","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-043476","line_url":"/filing/0001209191-18-043476#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":null,"owner_name":"NEA 15 GP, LLC; NEA Partners 15, L.P.; Growth Equity Opportunities IV, LLC; New Enterprise Associates 15, L.P.","owner_display_name":"NEA 15 GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50600.0,"shares_display":"50,600","price_per_share":1.9993,"price_display":"2.00","price_state":"stated","total_value":101164.58,"total_display":"101,164.58","total_whole":"101,165","shares_owned_after":18034322.0,"shares_owned_after_display":"18,034,322","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-19","filed_date":"2018-07-20","scope":"insider"},{"id":6726439,"accession":"0001209191-18-043476","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-043476","line_url":"/filing/0001209191-18-043476#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":null,"owner_name":"NEA 15 GP, LLC; NEA Partners 15, L.P.; Growth Equity Opportunities IV, LLC; New Enterprise Associates 15, L.P.","owner_display_name":"NEA 15 GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":1.9529,"price_display":"1.95","price_state":"stated","total_value":390580.0,"total_display":"390,580.00","total_whole":"390,580","shares_owned_after":17983722.0,"shares_owned_after_display":"17,983,722","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-18","filed_date":"2018-07-20","scope":"insider"},{"id":6660923,"accession":"0001209191-18-039956","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-039956","line_url":"/filing/0001209191-18-039956#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":null,"owner_name":"NEA 15 GP, LLC; NEA Partners 15, L.P.; Growth Equity Opportunities IV, LLC; New Enterprise Associates 15, L.P.","owner_display_name":"NEA 15 GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":187130.0,"shares_display":"187,130","price_per_share":2.0985,"price_display":"2.10","price_state":"stated","total_value":392692.305,"total_display":"392,692.30","total_whole":"392,692","shares_owned_after":17783722.0,"shares_owned_after_display":"17,783,722","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-28","filed_date":"2018-06-28","scope":"insider"},{"id":6660913,"accession":"0001209191-18-039956","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-039956","line_url":"/filing/0001209191-18-039956#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":null,"owner_name":"NEA 15 GP, LLC; NEA Partners 15, L.P.; Growth Equity Opportunities IV, LLC; New Enterprise Associates 15, L.P.","owner_display_name":"NEA 15 GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5295.0,"shares_display":"5,295","price_per_share":2.15,"price_display":"2.15","price_state":"stated","total_value":11384.25,"total_display":"11,384.25","total_whole":"11,384","shares_owned_after":17596592.0,"shares_owned_after_display":"17,596,592","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-27","filed_date":"2018-06-28","scope":"insider"},{"id":6016920,"accession":"0001209191-18-034183","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-034183","line_url":"/filing/0001209191-18-034183#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":null,"owner_name":"NEA 15 GP, LLC; New Enterprise Associates 15, L.P.; Growth Equity Opportunities IV, LLC; NEA Partners 15, L.P.","owner_display_name":"NEA 15 GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":275.0,"shares_display":"275","price_per_share":2.15,"price_display":"2.15","price_state":"stated","total_value":591.25,"total_display":"591.25","total_whole":"591","shares_owned_after":17591297.0,"shares_owned_after_display":"17,591,297","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-30","filed_date":"2018-05-30","scope":"insider"},{"id":6076504,"accession":"0001209191-18-031981","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-031981","line_url":"/filing/0001209191-18-031981#line-3","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":null,"owner_name":"NEA Partners 15, L.P.; New Enterprise Associates 15, L.P.; Growth Equity Opportunities IV, LLC; NEA 15 GP, LLC","owner_display_name":"NEA Partners 15, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":32200.0,"shares_display":"32,200","price_per_share":2.1447,"price_display":"2.14","price_state":"stated","total_value":69059.34,"total_display":"69,059.34","total_whole":"69,059","shares_owned_after":17591022.0,"shares_owned_after_display":"17,591,022","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-21","filed_date":"2018-05-21","scope":"insider"},{"id":6076502,"accession":"0001209191-18-031981","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-031981","line_url":"/filing/0001209191-18-031981#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":null,"owner_name":"NEA Partners 15, L.P.; New Enterprise Associates 15, L.P.; Growth Equity Opportunities IV, LLC; NEA 15 GP, LLC","owner_display_name":"NEA Partners 15, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20100.0,"shares_display":"20,100","price_per_share":2.1357,"price_display":"2.14","price_state":"stated","total_value":42927.57,"total_display":"42,927.57","total_whole":"42,928","shares_owned_after":17558822.0,"shares_owned_after_display":"17,558,822","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-18","filed_date":"2018-05-21","scope":"insider"},{"id":6076500,"accession":"0001209191-18-031981","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-031981","line_url":"/filing/0001209191-18-031981#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":null,"owner_name":"NEA Partners 15, L.P.; New Enterprise Associates 15, L.P.; Growth Equity Opportunities IV, LLC; NEA 15 GP, LLC","owner_display_name":"NEA Partners 15, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":184179.0,"shares_display":"184,179","price_per_share":2.1253,"price_display":"2.13","price_state":"stated","total_value":391435.6287,"total_display":"391,435.63","total_whole":"391,436","shares_owned_after":17538722.0,"shares_owned_after_display":"17,538,722","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-17","filed_date":"2018-05-21","scope":"insider"},{"id":6801388,"accession":"0001209191-18-029293","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-029293","line_url":"/filing/0001209191-18-029293#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":null,"owner_name":"NEA 15 GP, LLC; New Enterprise Associates 15, L.P.; NEA Partners 15, L.P.; Growth Equity Opportunities IV, LLC","owner_display_name":"NEA 15 GP, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":70873.0,"shares_display":"70,873","price_per_share":2.1341,"price_display":"2.13","price_state":"stated","total_value":151250.0693,"total_display":"151,250.07","total_whole":"151,250","shares_owned_after":17354543.0,"shares_owned_after_display":"17,354,543","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-08","filed_date":"2018-05-10","scope":"insider"},{"id":6759451,"accession":"0001209191-18-024532","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-024532","line_url":"/filing/0001209191-18-024532#line-3","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":null,"owner_name":"Growth Equity Opportunities IV, LLC; New Enterprise Associates 15, L.P.; NEA 15 GP, LLC; NEA Partners 15, L.P.","owner_display_name":"Growth Equity Opportunities IV, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":203200.0,"shares_display":"203,200","price_per_share":2.4606,"price_display":"2.46","price_state":"stated","total_value":499993.92,"total_display":"499,993.92","total_whole":"499,994","shares_owned_after":17283670.0,"shares_owned_after_display":"17,283,670","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-10","filed_date":"2018-04-10","scope":"insider"},{"id":6759448,"accession":"0001209191-18-024532","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-024532","line_url":"/filing/0001209191-18-024532#line-2","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":null,"owner_name":"Growth Equity Opportunities IV, LLC; New Enterprise Associates 15, L.P.; NEA 15 GP, LLC; NEA Partners 15, L.P.","owner_display_name":"Growth Equity Opportunities IV, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":32100.0,"shares_display":"32,100","price_per_share":2.433,"price_display":"2.43","price_state":"stated","total_value":78099.3,"total_display":"78,099.30","total_whole":"78,099","shares_owned_after":17080470.0,"shares_owned_after_display":"17,080,470","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-09","filed_date":"2018-04-10","scope":"insider"},{"id":6759445,"accession":"0001209191-18-024532","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-024532","line_url":"/filing/0001209191-18-024532#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":null,"owner_name":"Growth Equity Opportunities IV, LLC; New Enterprise Associates 15, L.P.; NEA 15 GP, LLC; NEA Partners 15, L.P.","owner_display_name":"Growth Equity Opportunities IV, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":685676.0,"shares_display":"685,676","price_per_share":2.2415,"price_display":"2.24","price_state":"stated","total_value":1536942.754,"total_display":"1,536,942.75","total_whole":"1,536,943","shares_owned_after":17048370.0,"shares_owned_after_display":"17,048,370","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-06","filed_date":"2018-04-10","scope":"insider"},{"id":6701100,"accession":"0001209191-18-013927","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-013927","line_url":"/filing/0001209191-18-013927#line-1","is_derivative":false,"issuer_cik":"0000907654","issuer_name":"ARCA biopharma, Inc.","issuer_ticker":"ABIO","issuer_name_source":null,"issuer_url":"/issuer/0000907654","owner_cik":null,"owner_name":"Growth Equity Opportunities IV, LLC; NEA Partners 15, L.P.; NEA 15 GP, LLC; New Enterprise Associates 15, L.P.","owner_display_name":"Growth Equity Opportunities IV, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1460209.0,"shares_display":"1,460,209","price_per_share":0.5008,"price_display":"0.50","price_state":"stated","total_value":731272.6672,"total_display":"731,272.67","total_whole":"731,273","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-26","filed_date":"2018-02-27","scope":"insider"},{"id":4623384,"accession":"0001209191-17-023485","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-023485","line_url":"/filing/0001209191-17-023485#line-1","is_derivative":false,"issuer_cik":"0001325879","issuer_name":"AVEO PHARMACEUTICALS INC","issuer_ticker":"AVEO","issuer_name_source":null,"issuer_url":"/issuer/0001325879","owner_cik":null,"owner_name":"NEA Partners 15, L.P.; Growth Equity Opportunities IV, LLC; New Enterprise Associates 15, L.P.; NEA 15 GP, LLC","owner_display_name":"NEA Partners 15, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000000.0,"shares_display":"6,000,000","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":16362694.0,"shares_owned_after_display":"16,362,694","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-28","filed_date":"2017-03-29","scope":"insider"},{"id":2674150,"accession":"0001209191-16-155933","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-155933","line_url":"/filing/0001209191-16-155933#line-1","is_derivative":false,"issuer_cik":"0001301501","issuer_name":"Achaogen Inc","issuer_ticker":"AKAO","issuer_name_source":null,"issuer_url":"/issuer/0001301501","owner_cik":null,"owner_name":"Growth Equity Opportunities IV, LLC; NEA 15 GP, LLC; New Enterprise Associates 15, L.P.; NEA Partners 15, L.P.","owner_display_name":"Growth Equity Opportunities IV, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":13.5,"price_display":"13.50","price_state":"stated","total_value":6750000.0,"total_display":"6,750,000.00","total_whole":"6,750,000","shares_owned_after":5215128.0,"shares_owned_after_display":"5,215,128","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-19","filed_date":"2016-12-19","scope":"insider"},{"id":2739179,"accession":"0001209191-16-133478","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-133478","line_url":"/filing/0001209191-16-133478","is_derivative":false,"issuer_cik":"0001437402","issuer_name":"ARDELYX, INC.","issuer_ticker":"ARDX","issuer_name_source":null,"issuer_url":"/issuer/0001437402","owner_cik":"0001640033","owner_name":"NEA 15 GP, LLC","owner_display_name":"NEA 15 GP, LLC","owner_url":"/insider/0001640033","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1527301.0,"shares_display":"1,527,301","price_per_share":8.73,"price_display":"8.73","price_state":"stated","total_value":13333337.73,"total_display":"13,333,337.73","total_whole":"13,333,338","shares_owned_after":2665520.0,"shares_owned_after_display":"2,665,520","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-07-18","filed_date":"2016-07-20","scope":"insider","n_lines":2},{"id":2309006,"accession":"0001209191-16-091420","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-091420","line_url":"/filing/0001209191-16-091420","is_derivative":false,"issuer_cik":"0001437402","issuer_name":"ARDELYX, INC.","issuer_ticker":"ARDX","issuer_name_source":null,"issuer_url":"/issuer/0001437402","owner_cik":"0001640033","owner_name":"NEA 15 GP, LLC","owner_display_name":"NEA 15 GP, LLC","owner_url":"/insider/0001640033","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000000.0,"shares_display":"1,000,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","total_whole":"10,000,000","shares_owned_after":1901869.0,"shares_owned_after_display":"1,901,869","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-01-13","filed_date":"2016-01-14","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001671284","name":"NeueHealth, Inc.","url":"/issuer/0001671284","role":"Director, Ten percent owner","n_filings":1,"first_seen":"2025-10-06","last_seen":"2025-10-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001786205","name":"Arcellx, Inc.","url":"/issuer/0001786205","role":"Ten percent owner","n_filings":2,"first_seen":"2022-02-09","last_seen":"2022-06-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001824920","name":"IonQ, Inc.","url":"/issuer/0001824920","role":"Ten percent owner","n_filings":1,"first_seen":"2022-05-31","last_seen":"2022-05-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001637715","name":"Reneo Pharmaceuticals, Inc.","url":"/issuer/0001637715","role":"Ten percent owner","n_filings":1,"first_seen":"2021-04-15","last_seen":"2021-04-15"},{"type":"issuer","type_label":"ISSUER","cik":"0001719395","name":"Eargo, Inc.","url":"/issuer/0001719395","role":"Ten percent owner","n_filings":1,"first_seen":"2020-10-22","last_seen":"2020-10-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001693011","name":"Inozyme Pharma, Inc.","url":"/issuer/0001693011","role":"Ten percent owner","n_filings":1,"first_seen":"2020-07-28","last_seen":"2020-07-28"},{"type":"issuer","type_label":"ISSUER","cik":"0001787400","name":"Nkarta, Inc.","url":"/issuer/0001787400","role":"Ten percent owner","n_filings":1,"first_seen":"2020-07-16","last_seen":"2020-07-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001325879","name":"AVEO PHARMACEUTICALS, INC.","url":"/issuer/0001325879","role":"Ten percent owner","n_filings":16,"first_seen":"2017-03-29","last_seen":"2020-06-22"},{"type":"issuer","type_label":"ISSUER","cik":"0000907654","name":"ARCA biopharma, Inc.","url":"/issuer/0000907654","role":"Ten percent owner","n_filings":1,"first_seen":"2018-02-27","last_seen":"2018-02-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001301501","name":"Achaogen Inc","url":"/issuer/0001301501","role":"Ten percent owner","n_filings":1,"first_seen":"2016-12-19","last_seen":"2016-12-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001437402","name":"ARDELYX, INC.","url":"/issuer/0001437402","role":"Ten percent owner","n_filings":2,"first_seen":"2016-01-14","last_seen":"2016-07-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001640033","retrieved_at":"2026-08-23T12:52:46+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}